Product information

Current status:

Cancelled Post Market

Current status date:

1999-08-04

Original market date: ^{See footnote 1}

1954-12-31

Product name:

SERPASIL 0.25MG

DIN:

00005665 Electronic product monograph is not available

Company:

NOVARTIS PHARMACEUTICALS CANADA INC
100 700 Rue Saint-Hubert
Montreal
Quebec
Canada H2Y 0C1

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

American Hospital Formulary Service (AHFS): ^{See footnote 3}

24:08.32 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

C02AA02 RESERPINE

Active ingredient group (AIG) number:^{See footnote5}

0104657001